Engineering mouse cell fate controller by rational design

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Cell fate decisions are governed by complex molecular machinery.
• Identifying key components regulating these processes is crucial for understanding development and disease.

Purpose of the Study:

• To design and test an engineered cell fate controller, Nanog^BiD, for enhanced somatic cell reprogramming.
• To elucidate the molecular mechanisms by which Nanog^BiD facilitates cell fate transition.

Main Methods:

• Fusion of the BRG1-interacting domain (BiD) of SS18 with Nanog to create Nanog^BiD.
• Testing Nanog^BiD efficiency in mouse somatic cell reprogramming under various conditions.
• Mechanistic studies involving chromatin accessibility assays and gene expression analysis.

Main Results:

• Engineered Nanog^BiD demonstrated significantly higher efficiency in mouse somatic cell reprogramming compared to native Nanog.
• Nanog^BiD facilitates cell fate transition by recruiting the Brg/Brahma-associated factor (BAF) complex.
• This recruitment modulates chromatin accessibility and reorganizes cell-state-specific enhancers, leading to precocious activation of pluripotency genes.

Conclusions:

• Engineered chromatin regulators like Nanog^BiD offer powerful tools for precise cell fate engineering.
• The findings suggest potential therapeutic applications in the emerging field of cell-based therapies.
• Further studies are needed to evaluate this approach in other species.